Health-related quality of life (HRQoL) assessment for patients with advanced renal cell carcinoma (aRCC) treated with a tyrosine kinase inhibitor (TKI) using electronic patient reported outcomes in daily clinical practice: QUANARIE trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreHealth-related quality of life (HRQoL) assessment for patients with advanced renal cell carcinoma (aRCC) treated with a tyrosine kinase inhibitor (TKI) using electronic patient reported outcomes in daily clinical practice: QUANARIE trial
Type de publicationJournal Article
Year of Publication2020
AuteursMouillet G., Falcoz A., Barthelemy P., Geoffrois L., Ladoire S., Eymard J-C., Plaza J., Viel E., Maurina T., Calcagno F., Stein U., Fritzsch J., Djoumakh O., Paget-Bailly S., Thiery-Vuillemin A.
JournalANNALS OF ONCOLOGY
Volume31
PaginationS1069
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2020.08.1525